Oncolytic Virus Therapy Market Report – Research, Industry Analysis Reports and Market Demands

Global Oncolytic Virus Therapy Market Growth (Status and Outlook) 2019-2024

Request for Sample of this report

Buy now

Table of Content

2019-2024 Global Oncolytic Virus Therapy Market Report (Status and Outlook)

1 Scope of the Report

2 Executive Summary

2.1 World Market Overview
- 2.1.1 Global Oncolytic Virus Therapy Market Size 2014-2024
- 2.1.2 Oncolytic Virus Therapy Market Size CAGR by Region
2.2 Oncolytic Virus Therapy Segment by Type
- 2.2.1 HSV-based Oncolytic Viruses
- 2.2.2 Adenoviruses-based Oncolytic Viruses
- 2.2.3 Vaccinia Virus-based Oncolytic Viruses
- 2.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
- 2.2.5 Newcastle Disease Virus-based Oncolytic Viruses
2.3 Oncolytic Virus Therapy Market Size by Type
- 2.3.1 Global Oncolytic Virus Therapy Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Oncolytic Virus Therapy Market Size Growth Rate by Type (2014-2019)
2.4 Oncolytic Virus Therapy Segment by Application
- 2.4.1 Melanoma
- 2.4.2 Prostate Cancer
- 2.4.3 Breast Cancer
- 2.4.4 Ovarian Cancer
- 2.4.5 Others
2.5 Oncolytic Virus Therapy Market Size by Application
- 2.5.1 Global Oncolytic Virus Therapy Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Oncolytic Virus Therapy Market Size Growth Rate by Application (2014-2019)

3 Global Oncolytic Virus Therapy by Players

3.1 Global Oncolytic Virus Therapy Market Size Market Share by Players
- 3.1.1 Global Oncolytic Virus Therapy Market Size by Players (2017-2019)
- 3.1.2 Global Oncolytic Virus Therapy Market Size Market Share by Players (2017-2019)
3.2 Global Oncolytic Virus Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Oncolytic Virus Therapy by Regions

4.1 Oncolytic Virus Therapy Market Size by Regions
4.2 Americas Oncolytic Virus Therapy Market Size Growth
4.3 APAC Oncolytic Virus Therapy Market Size Growth
4.4 Europe Oncolytic Virus Therapy Market Size Growth
4.5 Middle East & Africa Oncolytic Virus Therapy Market Size Growth

5 Americas

5.1 Americas Oncolytic Virus Therapy Market Size by Countries
5.2 Americas Oncolytic Virus Therapy Market Size by Type
5.3 Americas Oncolytic Virus Therapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Oncolytic Virus Therapy Market Size by Countries
6.2 APAC Oncolytic Virus Therapy Market Size by Type
6.3 APAC Oncolytic Virus Therapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Oncolytic Virus Therapy by Countries
7.2 Europe Oncolytic Virus Therapy Market Size by Type
7.3 Europe Oncolytic Virus Therapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Oncolytic Virus Therapy by Countries
8.2 Middle East & Africa Oncolytic Virus Therapy Market Size by Type
8.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Oncolytic Virus Therapy Market Forecast

10.1 Global Oncolytic Virus Therapy Market Size Forecast (2019-2024)
10.2 Global Oncolytic Virus Therapy Forecast by Regions
- 10.2.1 Global Oncolytic Virus Therapy Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
10.7 Global Oncolytic Virus Therapy Forecast by Type
10.8 Global Oncolytic Virus Therapy Forecast by Application

11 Key Players Analysis

12 Research Findings and Conclusion

Description

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
The application of oncolytic virus therapy includes melanoma, prostate cancer, breast cancer, ovarian cancer and others, and the proportion of R&D Investment for melanoma in 2017 is about 34%.
Market competition is intense. Amgen, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry.

According to this study, over the next five years the Oncolytic Virus Therapy market will register a 25.8% CAGR in terms of revenue, the global market size will reach US$ 10 million by 2024, from US$ 2 million in 2019. In particular, this report presents the global revenue market share of key companies in Oncolytic Virus Therapy business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Oncolytic Virus Therapy market by product type, application, key companies and key regions.

This study considers the Oncolytic Virus Therapy value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Oncolytic Virus Therapy market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Oncolytic Virus Therapy market by identifying its various subsegments.
Focuses on the key global Oncolytic Virus Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Oncolytic Virus Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Oncolytic Virus Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.